Immunocore Holdings plc (IMCR) Misses Q2 EPS by 2c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q2 EPS of ($0.20), $0.02 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $98 million versus the consensus estimate of $92.04 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• Goldman Sachs Adjust Monthly US Director's Cut List
• BTIG Upgrades Tidewater Inc (TDW) to Buy, 'Increasing Activity Set To Push Dayrates Higher in Key Basins'
• FireFox Gold Drills Downdip Extension of East Zone, including 1.0m at 124 g/t Au at the Mustajärvi Project in Lapland, Finland